Academic Training in Oncology at the University of North Carolina at Chapel Hill

描述（由申请人提供）：该T32将在北卡罗来纳州查佩尔山大学每年培训2名肿瘤学研究员“临床转化和人口科学”。学员将通过教学法，实践研究和学术产品的准备获得基本能力，以便在研究密集型学术中心开始临床转化研究或人口科学的职业生涯。学员还将准备从各种来源竞争研究资金，包括，如果他们留在斯坦福大学，保罗卡拉布雷斯K12。 领导该计划将由血液学/肿瘤学部门主任Richard Goldberg博士和Lineberger综合癌症中心主任谢尔顿厄普博士以及肿瘤学和公共卫生学院副教授Paul Godley博士指导。学院：有39名才华横溢的教师导师代表临床，基础和人口研究。导师是根据研究计划，资金和培训经验选择的。资源包括一个800张病床的三级保健医院，住院一般临床研究中心，广泛的研究实验室设施，并在2009年，北卡罗来纳州癌症医院。优秀的方案提供给学员包括胸部，泌尿生殖系统，皮肤病，神经肿瘤以及胃肠道和乳腺癌研究计划与孢子资金整合。Lineberger癌症研究项目涉及细胞生物学、免疫学、致癌作用、分子治疗学、病毒学、遗传学、癌症预防和控制以及流行病学。受训人员：受训人员将从成人和儿童肿瘤学培训项目的竞争性申请者中选出。申请由一个由领导和研究金主任组成的指导委员会审查。计划：每一个被选中的学员被分配至少2个导师，每个导师代表不同的研究领域。学员将花费75%的时间参加所需的K30课程和可选的教学法，在导师的监督下开发和开展他们的研究项目，培训负责任的研究行为，并学习如何在讲座，海报，手稿和第一批拨款申请中展示他们的研究。这两个轨道的学员将参加翻译研讨会系列，这是专门为这个程序开发的。这个多年的研讨会介绍了肿瘤学的新发现，组织在30个主题，并没有在其他地方提供。对学员，教师和整个计划的评估将每年由所有参与者，指导委员会以及内部和外部咨询委员会进行。 这项培训将是独一无二的，将有助于确保我们的肿瘤学学员准备开始研究生涯，最终将改善患者的结果。

DESCRIPTION (provided by applicant): This T32 will train 2 oncology fellows per year in "Clinical Translational and Population Science" at the University of North Carolina Chapel Hill. Trainees will obtain the fundamental competencies via didactics, hands-on research, and preparation of scholarly products needed to begin careers in clinical translational research or population sciences at research-intensive academic centers. Trainees will also be prepared to compete for research funding from a variety of sources, including, if they remain at UNC, the Paul Calabrese K12. Leadership. The program will be directed by Dr. Richard Goldberg, Chief of the Division of Hematology/Oncology and UNC Hospitals Cancer Center and Associate Directors, Dr Shelton Earp, Director of the Lineberger Comprehensive Cancer Center, and Dr Paul Godley, Associate Professor in Oncology and the School of Public Health. Faculty: There are 39 talented faculty mentors representing clinical, basic, and population research. Mentors have been selected based on research program, funding, and training experience. Resources include an 800 bed tertiary care hospital, an inpatient general clinical research center, extensive research laboratory facilities, and in 2009, the North Carolina Cancer Hospital. Outstanding programs available to trainees include thoracic, genitourinary, dermatologic, and neuro oncology as well as gastrointestinal and breast cancer research programs integrated with SPORE funding. Lineberger Cancer Research programs can be accessed that involve cell biology, immunology, carcinogenesis, molecular therapeutics, virology, genetics, cancer prevention and control and epidemiology. Trainees: Trainees will be selected from a competitive pool of applicants drawn from the adult and pediatric oncology training programs. Applications are reviewed by a steering committee comprising leadership and fellowship directors. Program: Each trainee selected is assigned at least 2 mentors with each mentor representing a different spectrum of research. Trainees will spend 75% of their time attending required K30 courses and optional didactics, developing and conducting their research project(s) under their mentors' supervision, training in Responsible Conduct of Research, and learning how to present their research in talks, posters, manuscripts, and first grant applications. Trainees in both tracks will participate in the Translational Seminar Series which has been especially developed for this program. This multi-year seminar presents the emerging discoveries in oncology organized across 30 topics and is not available elsewhere at UNC. Evaluation of the trainees, faculty and the program as a whole will be done on an annual basis by all of the participants, the steering committee and by the internal and external advisory committees. This training will be unique at UNC and will help ensure that our oncology trainees are prepared to begin research careers that will ultimately improve patient outcomes.